T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New diabetes drug shows promise in major trial
Disease control CompletedThis study tested whether a new medication called HTD1801 could help lower blood sugar in adults with type 2 diabetes that wasn't well controlled by diet and exercise alone. Over 400 participants were randomly assigned to take either HTD1801 or a placebo pill for 24 weeks, follow…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE3 • Sponsor: HighTide Biopharma Pty Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Better blood sugar control linked to faster UTI recovery in diabetics
Disease control CompletedThis study looked at how blood sugar levels affect treatment for repeated urinary tract infections (UTIs) in people with type 2 diabetes. It followed 99 patients, comparing those with good and poor blood sugar control. The results show that managing diabetes well can help antibio…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Al-Mustansiriyah University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New pill challenges standard diabetes treatment in major trial
Disease control CompletedThis study tested if a new drug called HTD1801 works as well as an established drug, dapagliflozin, for lowering blood sugar in people with type 2 diabetes. It involved 367 adults whose diabetes wasn't well-controlled on metformin alone. For 24 weeks, participants took either the…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE3 • Sponsor: HighTide Biopharma Pty Ltd • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New drug trial offers hope for teens battling diabetes
Disease control CompletedThis study tested a medication called tirzepatide in children and teenagers (ages 10-17) whose type 2 diabetes was not well-controlled with standard treatments like metformin or insulin. Over 60 weeks, researchers compared the drug to a placebo to see if it could better lower blo…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC
-
Could your voice reveal diabetes? AI study tests new screening method
Diagnosis CompletedThis study aimed to find out if a computer program could detect Type 2 diabetes by analyzing a person's voice. Over 7,300 adults in the UK recorded their voice and answered health questions online. The goal was to see if this voice analysis could be as useful as a standard blood …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Thymia Limited • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC